Pivotal Trials Will Address Diversity With New FDA Initiative ...Middle East

Medscape - News
Expected sometime in 2025, details on plans for enrollment by race, ethnicity, age, and sex will be required for all pivotal and phase 3 trials, according to a new FDA initiative. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Pivotal Trials Will Address Diversity With New FDA Initiative )

Apple Storegoogle play

Also on site :